- Home
- BHST vs NKTR Comparison
BHST vs NKTR Comparison
Compare BHST & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHST
- NKTR
- Stock Information
- Founded
- BHST 2007
- NKTR 1990
- Country
- BHST Canada
- NKTR United States
- Employees
- BHST N/A
- NKTR N/A
- Industry
- BHST
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- BHST
- NKTR Health Care
- Exchange
- BHST Nasdaq
- NKTR Nasdaq
- Market Cap
- BHST 106.0M
- NKTR 108.3M
- IPO Year
- BHST N/A
- NKTR 1994
- Fundamental
- Price
- BHST N/A
- NKTR $24.76
- Analyst Decision
- BHST Strong Buy
- NKTR Strong Buy
- Analyst Count
- BHST 2
- NKTR 6
- Target Price
- BHST $13.00
- NKTR $77.50
- AVG Volume (30 Days)
- BHST 8.9K
- NKTR 4.6M
- Earning Date
- BHST 08-15-2025
- NKTR 08-07-2025
- Dividend Yield
- BHST N/A
- NKTR N/A
- EPS Growth
- BHST N/A
- NKTR N/A
- EPS
- BHST N/A
- NKTR N/A
- Revenue
- BHST $27,704,000.00
- NKTR $87,248,000.00
- Revenue This Year
- BHST $116.40
- NKTR N/A
- Revenue Next Year
- BHST $55.91
- NKTR N/A
- P/E Ratio
- BHST N/A
- NKTR N/A
- Revenue Growth
- BHST 74.76
- NKTR N/A
- 52 Week Low
- BHST $4.66
- NKTR $6.48
- 52 Week High
- BHST $7.86
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- BHST N/A
- NKTR 68.00
- Support Level
- BHST N/A
- NKTR $8.27
- Resistance Level
- BHST N/A
- NKTR $26.59
- Average True Range (ATR)
- BHST 0.00
- NKTR 3.71
- MACD
- BHST 0.00
- NKTR 1.18
- Stochastic Oscillator
- BHST 0.00
- NKTR 57.06
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.